Flavonoids and the CNS

Molecules

Volumn 16, Issue 2, 2011, Pages 1471-1485

  Jäger, Anna K ^a   Saaby, Lasse ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CNS; Flavonoids; GABA; MAO; Mental health

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); FLAVONOID;

BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CHEMISTRY; COGNITION; DIET; DRUG EFFECT; HUMAN; MEDICINAL PLANT; METABOLISM; NERVE DEGENERATION; PERMEABILITY; REVIEW;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; COGNITION; DIET; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; MONOAMINE OXIDASE; NERVE DEGENERATION; PERMEABILITY; PLANTS, MEDICINAL; RECEPTORS, GABA-A;

EID: 79952155950     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16021471     Document Type: Review

References (71)

1. Viola, H.; Wasowski, C.; Destein, M.L.; Wolfman, C.; Silveira, R.; Dajas, F.; Medina, J.H.; Paladini, A.C. Apigenin, a component of matricaria recutita flowers, is a central benzodiazepine receptors ligand with anxiolytic effects. Planta Med. 1995, 61, 213-216.
2. Jäger, A.K.; Krydsfeldt, K.; Rasmussen, H.B. Bioassay-guided isolation of apigenin with GABA-benzodiazepine activity from Tanacetum parthenium. Phytother. Res. 2009, 23, 1642-1644.
3. Aguirre-Hernandez, E.; Gonzalez-Trujano, M.E.; Martinez, A.L.; Moreno, J.; Kite, G.; Terrazas, T.; Soto-Hernandez, M. HPLC/MS analysis and anxiolytic-like effect of quercetin and kaempferol flavonoids from Tilia americana var. mexicana. J. Ethnopharmacol. 2010, 127, 91-97.
4. Saaby, L.; Rasmussen, H.B.; Jager, A.K. MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J. Ethnopharmacol. 2009, 121, 178-181.
5. Bruneton, J. Pharmacognosy. Phytochemistry. Medicinal Plants, 2nd ed.; Intercept Ltd.: Paris, France, 1999.
6. Németh, K.; Plumb, G.W.; Berrin, J.G.; Juge, N.; Jacob, R.; Naim, H.Y.; Williamson, G.; Swallow, D.M.; Kroon, P.A. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur. J. Nutr. 2003, 42, 29-42. (Pubitemid 36286303)
7. Day, A.J.; Canada, F.J.; Diaz, J.C.; Kroon, P.A.; Mclauchlan, R.; Faulds, C.B.; Plumb, G.W.; Morgan, M.R.; Williamson, G. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000, 468, 166-170. (Pubitemid 30110789)
8. Nemeth, K.; Plumb, G.W.; Berrin, J.G.; Juge, N.; Jacob, R.; Naim, H.Y.; Williamson, G.; Swallow, D.M.; Kroon, P.A. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur. J Nutr. 2003, 42, 29-42. (Pubitemid 36286303)
9. Berrin, J.G.; McLauchlan, W.R.; Needs, P.; Williamson, G.; Puigserver, A.; Kroon, P.A.; Juge, N. Functional expression of human liver cytosolic beta-glucosidase in Pichia pastoris. Insights into its role in the metabolism of dietary glucosides. Eur. J. Biochem. 2002, 269, 249-258. (Pubitemid 34107359)
10. Hollman, P.C.H. Absorption, bioavailability, and metabolism of flavonoids. Arch. Physiol. Biochem. 2004, 42, 74-83.
11. Hollman, P.C.H. Absorption, Bioavailability, and Metabolism of Flavonoids. Arch. Physiol. Biochem. 2004, 42, 74-83.
12. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747. (Pubitemid 41103873)
13. Spencer, J.P.E.; Chowrimootoo, G.; Choudhury, R.; Debnam, E.S.; Srai, S.K.; Rice-Evans, C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 1999, 458, 224-230. (Pubitemid 29428188)
14. Crespy, V.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; Remesy, C. Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. J. Nutr. 2001, 131, 2109-2114. (Pubitemid 32720639)
15. Boersma, M.G.; van der Woude, H.; Bogaards, J.; Boeren, S.; Vervoort, J.; Cnubben, N.H.P.; van Iersel, M.L.P.S.; van Bladeren, P.J.; Rietjens, I.M.C.M. Regioselectivity of phase 11 metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 2002, 15, 662-670. (Pubitemid 34535121)
16. Stalmach, A.; Troufflard, S.; Serafini, M.; Crozier, A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res. 2009, 53, S44-S53.
17. Lee, M.J.; Maliakal, P.; Chen, L.S.; Meng, X.F.; Bondoc, F.Y.; Prabhu, S.; Lambert, G.; Mohr, S.; Yang, C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin- 3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol. Biomarker. Prev. 2002, 11, 1025-1032. (Pubitemid 35192653)
18. Mullen, W.; Edwards, C.A.; Crozier, A. Absorption, excretion and metabolite profiling of methyl- , glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br. J. Nutr. 2006, 96, 107-116. (Pubitemid 44160903)
19. Jaganath, I.B.; Mullen, W.; Edwards, C.A.; Crozier, A. The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radical Res. 2006, 40, 1035-1046. (Pubitemid 44480544)
20. Mullen, W.; Archeveque, M.A.; Edwards, C.A.; Matsumoto, H.; Crozier, A. Bioavailability and metabolism of orange Juice flavanones in humans: Impact of a full-fat yogurt. J. Agr. Food. Chem. 2008, 56, 11157-11164.
21. Manach, C.; Morand, C.; Gil-Izquierdo, A.; Bouteloup-Demange, C.; Remesy, C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. 2003, 57, 235-242. (Pubitemid 36240474)
22. Setchell, K.D.R.; Faughnan, M.S.; Avades, T.; Zimmer-Nechemias, L.; Brown, N.M.; Wolfe, B.E.; Brashear, W.T.; Desai, P.; Oldfield, M.F.; Botting, N.P.; Cassidy, A. Comparing the pharmacokinetics of daidzein and genistein with the use of C-13-labeled tracers in premenopausal women. Am. J. Clin. Nutr. 2003, 77, 411-419. (Pubitemid 36133385)
23. Izumi, T.; Piskula, M.K.; Osawa, S.; Obata, A.; Tobe, K.; Saito, M.; Kataoka, S.; Kubota, Y.; Kikuchi, M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000, 130, 1695-1699. (Pubitemid 30451055)
24. Mullen, W.; Edwards, C.A.; Serafini, M.; Crozier, A. Bioavailability of pelargonidin-3-Oglucoside and its metabolites in humans following the ingestion of strawberries with and without cream. J. Agr. Food. Chem. 2008, 56, 713-719. (Pubitemid 351300235)
25. de Boer, A.G.; Gaillard, P.J. Drug targeting to the brain. Annu. Rev. Pharmacool. Toxicol. 2007, 47, 323-355.
26. Youdim, K.A.; Dobbie, M.S.; Kuhnle, G.; Proteggente, A.R.; Abbott, N.J.; Rice-Evans, C. Interaction between flavonoids and the blood-brain barrier: In vitro studies. J. Neurochem. 2003, 85, 180-192. (Pubitemid 36389708)
27. Rangel-Ordonez, L.; Noldner, M.; Schubert-Zsilavecz, M.; Wurglics, M. Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba Extract EGb 761. Planta Med. 2010, 76, 1683-1690.
28. Fernandez, S.P.; Central nervous system depressant action of flavonoid glycosides. Eur. J. Pharmacol. 2006, 539, 168-176. (Pubitemid 44208813)
29. Avallone, R.; Zanoli, P.; Puia, G.; Kleinschnitz, M.; Schreier, P.; Baraldi, M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem. Pharmacol. 2000, 59, 1387-1394. (Pubitemid 30177355)
30. Kavvadias, D.; Sand, P.; Youdim, K.A.; Qaiser, M.Z.; Rice-Evans, C.; Baur, R.; Sigel, E.; Rausch, W.D.; Riederer, P.; Schreier, P. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br. J. Pharmacol. 2004, 142, 811-820. (Pubitemid 38998095)
31. Wolfman, C.; Viola, H.; Paladini, A.; Dajas, F.; Medina, J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. Behav. 1994, 47, 1-4.
32. Huen, M.S.Y.; Leung, J.W.C.; Ng, W.; Lui, W.S.; Chan, M.N.S.; Wong, J.T.F.; Xue, H. 5,7- Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. Biochem. Pharmacol. 2003, 66, 125-132. (Pubitemid 36724906)
33. Adachi, N.; Tomonaga, S.; Tachibana, T.; Denbow, D.M.; Furuse, M. (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur. J. Pharmacol. 2006, 531, 171-175. (Pubitemid 43202231)
34. Mewett, K.N.; Fernandez, S.P.; Pasricha, A.K.; Pong, A.; Devenish, S.O.; Hibbs, D.E.; Chebib, M.; Johnston, G.A.R.; Hanrahan, J.R. Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABA(A) receptors. Biorg. Med. Chem. 2009, 17, 7156-7173.
35. Bruton, R.; Qume, M. [3H]-GABA binding to GABA-A and GABA-B sites on rat brain crude synaptic membranes. Methods Mol. Biol. 1999, 106, 27-35.
36. Wieland, H.A.; Luddens, H.; Seeburg, P.H. A Single Histidine in Gaba-A Receptors Is Essential for Benzodiazepine Agonist Binding. J. Biol. Chem. 1992, 267, 1426-1429.
37. Rang, H.; Dale, M.; Ritter, J.; Moore, P. Pharmacology, 6th ed.; Churchill Livingstone: Edinburgh, UK, 2007.
38. Svenningsen, A.B.; Madsen, K.D.; Liljefors, T.; Stafford, G.I.; van, S.J.; Jager, A.K. Biflavones from Rhus species with affinity for the GABA(A)/benzodiazepine receptor. J. Ethnopharmacol. 2006, 103, 276-280. (Pubitemid 41796928)
39. Medina, J.H.; Viola, H.; Wolfman, C.; Marder, M.; Wasowski, C.; Calvo, D.; Paladini, A.C. Overview - Flavonoids: A new family of benzodiazepine receptor ligands. Neurochem. Res. 1997, 22, 419-425. (Pubitemid 27184706)
40. Marder, M.; Paladini, A.C. GABA(A)-receptor ligands of flavonoid structure. Curr. Top. Med. Chem. 2002, 2, 853-867.
41. Wasowski, C.; Marder, M.; Viola, H.; Medina, J.H.; Paladini, A.C. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii. Planta Med. 2002, 68, 934-936. (Pubitemid 35239288)
42. Salah, S.M.; Jager, A.K. Two flavonoids from Artemisia herba-alba Asso with In vitro GABA(A)-benzodiazepine receptor activity. J. Ethnopharmacol. 2005, 99, 145-146. (Pubitemid 40569413)
43. Shen, X.L.; Nielsen, M.; Witt, M.R.; Sterner, O.; Bergendorff, O.; Khayyal, M. Inhibition of [Methyl-H-3]diazepam binding to rat brain membranes in vitro by dinatin and skrofulein. Acta Pharmacol. Sin. 1994, 15, 385-388. (Pubitemid 24285283)
44. Medina, J.H.; Paladini, A.C.; Wolfman, C.; Destein, M.L.; Calvo, D.; Diaz, L.E.; Pena, C. Chrysin (5,7-Di-Oh-Flavone), A naturally occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem. Pharmacol. 1990, 40, 2227-2231. (Pubitemid 20373980)
45. Jäger, A.; Almquist, J.; Vangsoe, S.; Stafford, G.; Adsersen, A.; Van Staden, J. Compounds from Mentha aquatica with affinity to the GABA-benzodiazepine receptor. S. Afr. J. Bot. 2007, 73, 518-521. (Pubitemid 47588479)
46. Nielsen, M.; Frokjaer, S.; Braestrup, C. High affinity of the naturally occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochem. Pharmacol. 1988, 37, 3285-3287.
47. Butterweck, V.; Nahrstedt, A.; Evans, J.; Hufeisen, S.; Rauser, L.; Savage, J.; Popadak, B.; Ernsberger, P.; Roth, B.L. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs. Psychopharmacology 2002, 162, 193-202. (Pubitemid 34743959)
48. Hansen, R.S.; Paulsen, I.; Davies, M. Determinants of amentoflavone interaction at the GABA(A) receptor. Eur. J. Pharmacol. 2005, 519, 199-207. (Pubitemid 41278538)
49. Pedersen, M.E.; Vestergaard, H.T.; Stafford, G.I.; van Staden, J.; Jager, A.K. The effect of extracts of Searsia species on epileptiform activity in slices of the mouse cerebral cortex. J. Ethnopharmacol. 2008, 119, 538-541.
50. Campbell, E.L.; Chebib, M.; Johnston, G.A.R. The dietary flavonoids apigenin and (-)- epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochem. Pharmacol. 2004, 68, 1631-1638. (Pubitemid 39286467)
51. Fernandez, S.P.; Wasowski, C.; Paladini, A.C.; Marder, M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur. J. Pharmacol. 2005, 512, 189-198. (Pubitemid 40544353)
52. Ren, L.H.; Wang, F.; Xu, Z.W.; Chan, W.M.; Zhao, C.Y.; Xue, H. GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone. Biochem. Pharmacol. 2010, 79, 1337-1344.
53. Edmondson, D.E.; Mattevi, A.; Binda, C.; Li, M.; Hubalek, F. Structure and mechanism of monoamine oxidase. Curr. Med. Chem. 2004, 11, 1983-1993. (Pubitemid 38967724)
54. Billett, E.E. Monoamine oxidase (MAO) in human peripheral tissues. Neurotoxicology 2004, 25, 139-148. (Pubitemid 38044175)
55. Youdim, M.B.H.; Weinstock, M. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology 2004, 25, 243-250. (Pubitemid 38044185)
56. Yamada, M.; Yasuhara, H. Clinical pharmacology of MAO inhibitors: Safety and future. Neurotoxicology 2004, 25, 215-221. (Pubitemid 38044183)
57. Sloley, B.D.; Urichuk, L.J.; Morley, P.; Durkin, J.; Shan, J.J.; Pang, P.K.T.; Coutts, R.T. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J. Pharm. Pharmacol. 2000, 52, 451-459. (Pubitemid 30223690)
58. Chimenti, F.; Cottiglia, F.; Bonsignore, L.; Casu, L.; Casu, M.; Floris, C.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F.; Trombetta, G.; Loizzo, A.; Guarino, I. Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: Extraction, biological analysis, and computational study. J. Nat. Prod. 2006, 69, 945-949. (Pubitemid 44166270)
59. Lee, M.H.; Lin, R.D.; Shen, L.Y.; Yang, L.L.; Yen, K.Y.; Hou, W.C. Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don. J. Agr. Food. Chem. 2001, 49, 5551-5555.
60. Hou, W.C.; Lin, R.D.; Chen, C.T.; Lee, M.H. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. J. Ethnopharmacol. 2005, 100, 216-220.
61. Hwang, J.S.; Lee, S.A.; Hong, S.S.; Lee, K.S.; Lee, M.K.; Hwang, B.Y.; Ro, J.S. Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Arch. Pharmacal. Res. 2005, 28, 190-194. (Pubitemid 43073672)
62. Olsen, H.T.; Stafford, G.I.; van Staden, J.; Christensen, S.B.; Jager, A.K. Isolation of the MAOinhibitor naringenin from Mentha aquatica L. J. Ethnopharmacol. 2008, 117, 500-502.
63. Dreiseitel, A.; Korte, G.; Schreier, P.; Oehme, A.; Locher, S.; Domani, M.; Hajak, G.; Sand, P.G. Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol. Res. 2009, 59, 306-311.
64. Spencer, J.P.E. The impact of fruit flavonoids on memory and cognition. Br. J. Nutr. 2010, 104, S40-S47.
65. Van Praag, H.; Lucero, M.J.; Yeo, G.W.; Stecker, K.; Heivand, N.; Zhao, C.; Yip, E.; Afanador, M.; Schroeter, H.; Hammerstone, J.; Gage, F.H. Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J. Neurosci. 2007, 27, 5869-5878. (Pubitemid 46849755)
66. Balzer, J.; Heiss, C.; Schroeter, H.; Brouzos, P.; Kleinbongard, P.; Matern, S.; Lauer, T.; Rassaf, T.; Kelm, M. Flavanols and cardiovascular health: Effects on the circulating NO pool in humans. J. Cardiovasc. Pharmacol. 2006, 47, S122-S127. (Pubitemid 44620202)
67. Schroeter, H.; Spencer, J.P.E.; Rice-Evans, C.; Williams, R.J. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c- Jun and caspase-3. Biochem. J. 2001, 358, 547-557. (Pubitemid 32896942)
68. Vauzour, D.; Vafeiadou, K.; Rice-Evans, C.; Williams, R.J.; Spencer, J.P.E. Activation of prosurvival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 103, 1355-1367. (Pubitemid 47631805)
69. Vafeiadou, K.; Vauzour, D.; Lee, H.Y.; Rodriguez-Mateos, A.; Williams, R.J.; Spencer, J.P.E. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys. 2009, 484, 100-109.
70. Chen, J.C.; Ho, F.M.; Chao, P.D.L.; Chen, C.P.; Jeng, K.C.G.; Hsu, H.B.; Lee, S.T.; Wu, W.T.; Lin, W.W. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of I kappa B kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol. 2005, 521, 9-20.
71. Li, R.; Huang, Y.G.; Fang, D.; Le, W.D. (-)-Epigallocatechin gallate inhibits lipopolysaccharideinduced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci. Res. 2004, 78, 723-731. (Pubitemid 39657589)